Aclaris Therapeutics
ACRS
ACRS
97 hedge funds and large institutions have $1.14B invested in Aclaris Therapeutics in 2021 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 32 increasing their positions, 26 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
23% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 26
18% more funds holding
Funds holding: 82 → 97 (+15)
13.27% more ownership
Funds ownership: 74.4% → 87.68% (+13%)
Holders
97
Holding in Top 10
15
Calls
$6.4M
Puts
$4.21M
Top Buyers
| 1 | +$61.7M | |
| 2 | +$50.4M | |
| 3 | +$44.5M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$32.6M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$32.4M |
Top Sellers
| 1 | -$16.9M | |
| 2 | -$12.4M | |
| 3 | -$9.77M | |
| 4 |
SB
Samsara BioCapital
Palo Alto,
California
|
-$8.57M |
| 5 |
CC
Commodore Capital
New York
|
-$7.77M |